Agendia Raises $23 Million

Agendia BV, a Dutch developer of molecular cancer diagnostics, has raised $23 million in Series E funding. An undisclosed family office led the round, and was joined by return backers ING, Van Herk Biotech, Gilde Healthcare Partners and Global Life Science Ventures. The company raised a $34 million fourth round in 2007, and has not disclosed financial information on its prior fundings.

North AmericaUSBriefs